LGVN (Longeveron) Ending Cash Position: $10.08 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LGVN Longeveron Inc LGVN
45 GF Score
Price $0.84
GF Value $0.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Longeveron Ending Cash Position?

Longeveron LGVN +2.29% 45 Ending Cash Position is $10.08 Mil as of Jun. 2026. GuruFocus rates LGVN with a GF Score™ of 45/100 and a GF Value™ of $0.32 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Longeveron's Ending Cash Position for the quarter that ended in Jun. 2026 was $10.08 Mil.

Longeveron's quarterly Ending Cash Position increased from Dec. 2025 ($4.66 Mil) to Mar. 2026 ($15.76 Mil) but then declined from Mar. 2026 ($15.76 Mil) to Jun. 2026 ($10.08 Mil).

Longeveron's annual Ending Cash Position increased from Dec. 2023 ($4.95 Mil) to Dec. 2024 ($19.23 Mil) but then declined from Dec. 2024 ($19.23 Mil) to Dec. 2025 ($4.66 Mil).

Longeveron Ending Cash Position Related Terms

Longeveron Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Longeveron's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longeveron Ending Cash Position Chart

Longeveron Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 25.66 10.50 4.95 19.23 4.66

Longeveron Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.33 9.24 4.66 15.76 10.08
LGVN
45GF Score
Longeveron Inc LGVN
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Longeveron Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Longeveron's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=19.232+-14.571
=4.66

Longeveron's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=15.758+-5.681
=10.08

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $10.08 Mil mean?
Longeveron (LGVN) has a Ending Cash Position of $10.08 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Longeveron and its competitors.
Is Longeveron's Ending Cash Position too high?
Longeveron's current Ending Cash Position is $10.08 Mil. Overall, Longeveron has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Longeveron's Ending Cash Position compare to TVGN and ALLR?
Longeveron's Ending Cash Position of $10.08 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Longeveron and its competitors. Longeveron's current Ending Cash Position is $10.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longeveron stock overvalued right now?
Based on GuruFocus' analysis, Longeveron (LGVN) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.32, compared to a current price of $0.84 — trading 162.5% above its estimated fair value. The current Ending Cash Position is $10.08 Mil. Longeveron's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Longeveron (LGVN), the current Ending Cash Position is $10.08 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Longeveron (LGVN) Overvalued in 2026?

Based on GuruFocus' analysis, Longeveron stock appears to be overvalued. The current stock price of $0.84 is trading 162.5% above its estimated GF Value™ of $0.32. GuruFocus considers Longeveron to be Significantly Overvalued.

Key valuation signals for LGVN:

  • Ending Cash Position: $10.08 Mil
  • GF Value™: $0.32 vs. price of $0.84 (162.5% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the LGVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Longeveron Business Description

Address 1951 NW 7th Avenue, Suite 520, Miami, FL, USA, 33136
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
45GF Score

Get the complete analysis for LGVN

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.84
Price
$0.32
GF Value